Abstract
The clearance of debris after injuries to the nervous system is a critical step for restoration of the injured neural network. Microglia are thought to be involved in elimination of degenerating neurons and axons in the central nervous system (CNS), presumably restoring a favorable environment after CNS injuries. However, the mechanism underlying debris clearance remains elusive. Here, we establish an in vitro assay system to estimate phagocytosis of axon debris. We employed a Wallerian degeneration model by cutting axons of the cortical explants. The cortical explants were co-cultured with primary microglia or the MG5 microglial cell line. The cortical neurites were then transected. MG5 cells efficiently phagocytosed the debris, whereas primary microglia showed phagocytic activity only when they were activated by lipopolysaccharide or interferon-β. When MG5 cells or primary microglia were co-cultured with degenerated axons, p38 mitogen-activated protein kinase (MAPK) was activated in these cells. Engulfment of axon debris was blocked by the p38 MAPK inhibitor SB203580, indicating that p38 MAPK is required for phagocytic activity. Receptors that recognize dying cells appeared not to be involved in the process of phagocytosis of the axon debris. In addition, the axons undergoing Wallerian degeneration did not release lactate dehydrogenase, suggesting that degeneration of the severed axons and apoptosis may represent two distinct self-destruction programs. We observed regrowth of the severed neurites after axon debris was removed. This finding suggests that axon debris, in addition to myelin debris, is an inhibitory factor for axon regeneration.
Axon degeneration is an active, tightly controlled, and versatile process of axon segment self-destruction. The lesion-induced degeneration process was first described by Waller (1) and has since been known as Wallerian degeneration (2, 3). This degeneration involves rapid blebbing and fragmentation of an entire axonal stretch into short segments, which are then removed by locally activated phagocytic cells. Phagocytic removal of damaged axons and their myelin sheaths distal to the injury is important for creating a favorable environment for axonal regeneration in the nervous system. Although the debris of degenerated axons and myelin is cleared by phagocytes in the peripheral nervous system (PNS), the debris is removed very slowly in the central nervous system (CNS)3 (4, 5). This is considered to be one of the obstacles for regeneration of the injured axons in the CNS.
Apoptotic neurons are also engulfed by activated phagocytic cells. Apoptosis is very well documented in the CNS where a significant proportion of neurons undergo programmed cell death (6). To prevent the diffusion of damaging degradation products into surrounding tissues, dying neurons are phagocytosed. In the brain, apoptotic cells are engulfed mainly by the resident population of phagocytes known as microglia. Microglia are generally considered to be immune cells of the CNS (7). They respond to any kind of pathology with a reaction termed “microglial activation.” After injuries to the CNS, microglia react within a few hours with a migratory response toward the lesion site.
Although insight into the mechanism of phagocytosis of dying cells by microglia has improved, little is known about the mechanism of clearance of degenerated axons and myelin debris by microglia after axonal injury in the CNS. Interestingly, the axons undergoing Wallerian degeneration do not seem to possess detectable activation of the caspase family (8), suggesting that Wallerian degeneration and apoptosis may represent two distinct self-destruction programs. Thus, the mechanism of microglial phagocytosis of dying cells might be different from that of axon/myelin debris. We aimed to elucidate the mechanism of debris clearance by microglia after an axonal injury. We established an in vitro assay system to estimate phagocytosis of degenerated axon debris. We found that p38 mitogen-activated protein kinase (MAPK) was critical for the phagocytic activity of microglia. Treatment with lipopolysaccharide (LPS) or interferon-β (IFN-β) was necessary for the primary microglia to become phagocytic. In addition, clearance of degenerated axon debris allowed axonal growth from the severed neurites, suggesting that removal of the axon debris provides a favorable environment for axonal regeneration.
EXPERIMENTAL PROCEDURES
Cell Cultures
Because the number of primary microglia that can be cultured from neonatal mice is limited, two cell culture lines were used. The MG5 microglial cell line derived from p53-deficient mice was cultured in A1-cell conditioned medium (9). A1 cells were cultured in DMEM supplemented with 10% fetal bovine serum. Primary cultures of microglial cells were obtained from Wistar rats on postnatal day 1 (P1). Briefly, the rat cerebral cortex was digested with 0.25% trypsin and 70 units DNase for 15 min. Cells were passed through a 70-μm nylon mesh. The resultant cell suspension was diluted with DMEM supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin and seeded into poly-l-lysine-coated several dishes. Microglial cells from the astrocyte-monolayer sheet were removed by shaking. Briefly, the conditioned medium was collected into the centrifuge tube. The medium-removed dishes were shaken for several times. Then, the medium was gently poured into the dishes and recollected. For cortical explant cultures, the cortex was removed from E14-E16 (C57BL/6J mouse) or E18-E20 (Wistar rat) according to previously reported methods, with a slight modification (10). The cortex was chopped into 300–600-μm-sized pieces using tungsten needles. The chopped cortex pieces were then placed in a 3.5-cm tissue culture dish containing 1 ml of DMEM/F12 supplemented with 10% fetal bovine serum. After 6 days of incubation at 37 °C in a humidified 95% air, 5% CO2 incubator, the medium was exchanged to DMEM/F12 supplemented with 2% B27 (Invitrogen, Carlsbad, CA). Primary microglia (4 × 105 cells) or MG5 cells (2 × 105 cells) were co-cultured. The extended neurites from the explant cortex culture were transected using a blade.
Reagents for Cell Cultures
The concentrations of reagents used in this study were as follows: 1 μg/ml LPS (Sigma-Aldrich), 300 units/ml IFN-β (Sigma-Aldrich), 50 μm SB203580 (a p38 MAPK inhibitor; Sigma-Aldrich), 100 μm kainic acid (Sigma-Aldrich), 10 μm MRS2578 (P2Y6 receptor antagonist; Sigma-Aldrich), and 0.5 μm staurosporine (BIOMOL, Plymouth Meeting, PA). The cells were pretreated with each inhibitor for 30 min before axotomy.
Time-lapse Imaging
The cortical explants and MG5 cells were co-cultured in a poly-l-lysine-coated dish for 12 h, and the neurites were then transected. The culture dish was then transferred to a heated stage apparatus (model MI-IBC-IF, Olympus, Tokyo, Japan). Time-lapse images were acquired every 8 min for 36 h with an Olympus IX81 microscope using a 10× objective lens. Images were combined into a time-lapsed sequence by using MetaMorph software (Molecular Devices, Sunnyvale, CA).
Fluorescent Immunostaining
Fluorescent immunostaining was performed at the end of the culture time. Cells were fixed in 4% paraformaldehyde in 0.1 m phosphate buffer for 1 h at room temperature and incubated with a blocking solution containing 1% bovine serum albumin and 0.1% Triton X-100 in phosphate-buffered saline for 1 h, followed by overnight incubation at 4 °C with anti-β-tubulin III (Tuj-1) antibody (diluted 1:1000 in the blocking solution; Covance, Princeton, NJ), anti-ED1 (CD68) antibody (diluted 1:100 in the blocking solution; AbD Serotec, Raleigh, NC), anti-GAP43 antibody (diluted 1:1000 in the blocking solution; Chemicon/Millipore, Temecula, CA), and anti-phospho-p38 antibody (diluted 1:100 in the blocking solution; Cell Signaling Technology, Beverly, MA). Fluorescent dye Alexa Fluor 488-conjugated anti-rabbit IgG or 568-conjugated anti-mouse IgG (diluted 1:1000 in phosphate-buffered saline containing 0.1% Triton X-100; Molecular Probes/Invitrogen) was used as the secondary antibody.
Western Blotting
Cells were lysed with 10 mm Tris buffer, pH 7.4, containing 150 mm NaCl, 5 mm EDTA, 1% Triton X-100, 1% deoxycholic acid, 0.1% SDS, 1 mm sodium vanadate, and protease inhibitor mixture (Roche Applied Science). The homogenate was centrifuged at 17,400 × g for 10 min, and the supernatant was stored at −20 °C. The protein concentration was measured using a bicinchoninic acid protein assay kit (Pierce). Equal amounts of protein were loaded into each lane, run on sodium dodecyl sulfate (SDS)-polyacrylamide gels, and then transferred to a polyvinylidene difluoride membrane (Millipore). The blots were probed with anti-phospho-MEK1/2 (1:1000; Cell Signaling Technology), anti-MEK1/2 (1:1000; Cell Signaling Technology), anti-phospho-c-Jun N-terminal kinase, (JNK, 1:5000; Promega, Madison, WI), anti-JNK (1:1000; Cell Signaling Technology), anti-phospho-p38 (1:1000; Cell Signaling Technology), and anti-p38 (1:500; Cell Signaling Technology). Immunoblot analysis was performed with horseradish peroxidase-conjugated anti-mouse and anti-rabbit IgG (Cell Signaling Technology) using enhanced chemiluminescence Western blotting detection reagents (GE Healthcare, Piscataway, NJ).
Lactate Dehydrogenase Release
The media of the explant cultures were collected and assayed for lactate dehydrogenase (LDH) activity using a cytotoxicity detection kit (Roche Applied Science). Briefly, LDH catalyzes the conversion of lactate to pyruvate upon reduction of NAD+ to NADH/H+; the added tetrazolium salt is reduced to formazan. The amount of formazan formed correlates with LDH activity. The formazan product was measured with a microtiter plate reader (Molecular Devices) at 490 nm.
Reverse Transcription-Polymerase Chain Reaction
Total RNA was extracted from the cells or spleen/brain with TRIzol (Invitrogen) and converted to cDNA by reverse transcriptase using a random primer to prime MultiScribe reverse transcriptase (Applied Biosystems) according to the manufacturer's instructions. Specific DNAs were mixed and amplified with 0.2 μm of each primer and cDNA. PCR primers used in this study were as follows: Tim-4 sense primer, 5′-GGCTCCTTCTCACAAGAAACCACA-3′; Tim-4 antisense primer, 5′-TCAGCTGTGAAGTGGATGGGAGA-3′; β-actin sense primer, 5′-TGTATGCCTCTGGTCGTACC-3′; and β-actin antisense primer, 5′-CAACGTCACACTTCATGATGG-3′. The PCR cycling conditions for Tim-4 were 5 min at 96 °C; multiple cycles of 30 s at 96 °C, 30 s at 60 °C, and 30 s at 72 °C; 32 cycles. For β-actin, the PCR-cycling conditions were 5 min at 96 °C; multiple cycles of 30 s at 96 °C, 30 s at 58 °C, and 30 s at 72 °C; 21 cycles. The PCR products were separated by electrophoresis on 1.5% agarose gels and visualized using ethidium bromide.
Statistical Analysis
The significant difference in data in Figs. 1 and 2 was calculated by Student's t test. Other data were subjected to one-way analysis of variance, and differences between treatment means were determined by the Tukey-Kramer method.
RESULTS
Establishment of an in Vitro Assay System to Estimate Phagocytosis of Axon Debris
To elucidate the function of microglia in debris clearance following axonal injury, we attempted to establish an assay system for microglial phagocytosis of axon debris in vitro. We employed the explant culture of the cerebral cortex from E14-E16 mice. At 6 days after explant culture, when numerous neurites were observed (Fig. 1A), we performed transection of the neurites by using a blade (Fig. 1B). The severed distal neurites began to develop signs of early degeneration, such as focal swelling and beading, ∼8 h after the axons had been separated from their cell bodies, namely, Wallerian degeneration (Fig. 1C). When the MG5 murine microglial cell line was co-cultured, the degenerated axon debris was partly cleared by the MG5 cells, whereas proximal neurites remained intact (Fig. 1D). To assess whether MG5 cells engulfed degenerating neurites, we immunostained the neurons and MG5 cells by anti-Tuj1 (green) and anti-ED1 (red) antibodies, respectively. The result demonstrated that these signals co-localized 36 h after axotomy (Fig. 1E). Thus, degenerated axon debris was cleared by phagocytosis by MG5 cells. Severed neurites became fragmented debris, consisting of microtubules and neurofilaments. We quantified the number of fragmented neurites by counting the Tuj1-positive particles. Quantitative analysis revealed that the residual axon debris was significantly reduced 36 h after transection if MG5 cells were co-cultured (reduced to 25.1% ± 7.4% of control) (Fig. 1F). To directly study the dynamic movement of MG5 cells during phagocytosis, we performed time-lapse analysis. The results shown in Fig. 1G and supplemental Movie S1 were based on time-lapse observations taken up to 36 h after transection. Live imaging showed that MG5 cells started to clear debris at ∼15 h and became highly motile afterward (supplemental Movie 1). Notably, engulfment was specific to the distal part of the severed neurites but not to the proximal part or to the cell bodies (Fig. 2, A–C). We then traced motile MG5 cells in the proximal (including cell bodies and proximal neurites) and distal (including transected distal neurites) regions from the transected site for up to 32 h and measured the distance of the movement in the two-dimensional field at 0–2, 10–12, 20–22, and 30–32 h (Fig. 2D). MG5 cells showed high motility, specifically in the distal region at 10–12 and 20–22 h, although little migration was observed in the proximal region during the observation period. We performed quantitative analysis of the microglial motility. MG5 cells became highly motile in the distal region (47.5 ± 12.6 μm/h) compared with the proximal region (13.3 ± 2.8 μm/h) (Fig. 2E). In addition, the cell bodies of some, but not all, MG5 cells in the distal region became hypertrophic in a time-dependent manner (Fig. 2F). These observations in vitro resembled those in vivo after injury to the nervous system. Thus, our in vitro assay system is a useful tool to analyze the mechanism of debris clearance by microglial cells.
Primary Microglia Require LPS or IFN-β to Become Phagocytic
We examined whether engulfment of degenerating axons was observed in primary cultures of microglia. Because primary microglial cells used in this study were obtained from Wistar rats on postnatal day 1 (P1), we employed the explant culture of the cerebral cortex from E18-E20 rats (6 days of incubation) (Fig. 3, A and B). Unlike MG5 cells, clearance of the debris was not efficient in primary microglia from rats (Fig. 3, A and B). Only 26% of the fragmented neurites were engulfed at 144 h after axotomy (compared with 74.9% by MG5 cells). This result suggests that neurite debris was not sufficient for induction of phagocytic activity from primary microglia. To assess whether activation of microglia was necessary for engulfment of debris, primary microglia were treated with 1 μg/ml LPS before axotomy. Clearance of the degenerated neurites by the primary microglia was strongly up-regulated by LPS at 96 h (reduced to 50.0% ± 4.2% of unstimulated control microglia) and 144 h (reduced to 8.1% ± 2.4% of unstimulated control microglia). It has been reported that IFN-β enhances the ability of microglia to phagocytose apoptotic T cells, thereby resulting in a suppression of the immune response (11). Therefore, we treated the primary microglia with 300 units/ml IFN-β. Clearance of the degenerated neurites by the primary microglia was also significantly up-regulated, but to a lesser extent than that with the LPS treatment, at 96 h (reduced to 55.7% ± 4.8% of control) and 144 h (reduced to 51.8% ± 2.5% of control). This quantitative analysis showed that a certain amount of time was required for primary microglia to acquire ability for engulfment (Fig. 3B). These results suggested that primary microglia are in a resting state in vitro and that LPS or IFN-β is required for the acquisition of phagocytic capability. However, it should be noted that activation of primary microglia by LPS or IFN-β is not sufficient for phagocytosis, as these activated microglia did not phagocytose the proximal axons or cell bodies (data not shown). Thus, microglia may need to recognize some signals on the degenerated axons to become phagocytic.
Axon Debris Inhibits Neurite Growth in Vitro
Next, we examined whether clearance of degenerated neurites was necessary for axonal growth from the severed neurites. The cortical explants were cultured for up to 96 h after transection in the presence or absence of MG5 cells, and fluorescent immunostaining was then performed using anti-Tuj1 and anti-ED1 antibodies. We found that numerous extended axons were observed distal to the transected site when degenerated debris was cleared by MG5 cells (Fig. 4, C and D). In contrast, no fibers could be seen beyond the site of transection if the debris was not cleared in the absence of MG5 cells (Fig. 4, A and B). Consistent results were obtained in the presence of primary microglia (Fig. 4, E and F). In this experiment, the cortical explants were cultured for up to 10 days after transection in the presence of primary microglia and LPS, as a certain amount of time was required for primary microglia to acquire the engulfment ability.
The above result raised the possibility that axon debris is an inhibitory factor for axon regeneration. Thus, we removed the distal neurites after transection with a scraper (Fig. 4G). Growth of the fibers beyond the transected site was observed in a few hours (data not shown). Seventy-two hours after removal of the debris, numerous fibers grew into the distal region from the transected site (Fig. 4, H and I). Regenerating axons express growth-associated phosphoprotein (GAP)43, which is widely used to specifically label injured neurons and to estimate axonal regeneration (12). We found that GAP43 was expressed at the growth cone of the regenerating axons (Fig. 4, J–L). Therefore, regrowth of the severed axons occurred if degenerated distal neurites were cleared. These data suggest that degenerated axon debris is a potent inhibitor of axon regeneration and that removal of the axon debris may provide a favorable environment for axonal regeneration after axonal injuries.
We further examined whether microglia may have a role in enhancing axonal regeneration. After the axon debris was physically removed with a scraper, we added microglia in the presence or absence of LPS. Thirty-six hours after removal of the debris, neurite outgrowth from the transected site was increased in the presence of microglia and LPS (504.8 ± 22.8 μm) compared with the control (325.1 ± 24.3 μm) (Fig. 5). In the presence of microglia without LPS, no significant increase in the neurite growth was observed (402.1 ± 25.8 μm) compared with the control (Fig. 5). These results suggest that activated microglia contribute to enhancing axonal regeneration.
p38 MAPK Is Associated with Phagocytic Activity of Microglia
Next, we attempted to explore the signaling pathways that regulate phagocytic activity of microglia. Previous reports have demonstrated that MAPK cascades are involved in microglial activation, which regulates cytokine production (13) and contributes to the generation of neuropathic pain (14). To investigate whether MAPKs are activated in phagocytic microglia, the phosphorylation levels of MEK1/2, JNK, and p38 MAPK were estimated by Western blot analysis using antibodies against the nonphosphorylated and phosphorylated proteins. The cortical explants and MG5 cells were co-cultured for 12 h, and the neurites were then transected. Degenerating axons (without proximal axons) and MG5 cells from 0–48 h after the transection were subjected to Western blot analysis. The phosphorylation level of MEK1/2 was unchanged during the observation period, whereas that of JNK was down-regulated at 12 h and thereafter (Fig. 6, A and B). However, the phosphorylation level of p38 MAPK in MG5 cells was up-regulated as early as 12 h, and this up-regulation persisted for 24 h (Fig. 6, A and B). We next examined whether activation of p38 MAPK was required for engulfment of debris. A specific pharmacological p38 MAPK inhibitor, SB203580, was employed to address this question. We found that the p38 MAPK inhibitor significantly blocked engulfment of degenerating neurites by MG5 cells (reduced to 74.0% ± 3.7% of control) (Fig. 6, C–F). We further examined whether the phosphorylation of p38 MAPK was observed in microglia or in degenerated axons. We performed immunostaining by using antibodies against the phospho-p38 MAPK and Tuj1 or ED1 14 h after transection. Although immunoreactivity for Tuj1 did not colocalize with that for phospho-p38 MAPK, ED-1-positive MG5 cells were positive for phospho-p38 MAPK (Fig. 6G). These results demonstrated that activation of p38 MAPK was observed in MG5 cells, but not in degenerated axons. Consistent with this result, we could not detect the band for phospho-p38 MAPK in the absence of MG5 cells by Western blot (Fig. 6H).
We next measured the phosphorylation levels of p38 MAPK by Western blot analysis in primary microglia. The phosphorylation level of p38 MAPK was increased 24 h after transection of axons (Fig. 6, I and J). As mentioned above, primary microglia are in a resting state in vitro, and LPS is required for the activation of primary microglia. Therefore, the above results raised the possibility that phosphorylation of p38 MAPK is induced by LPS. To exclude this possibility, LPS-induced phosphorylation level of p38 MAPK was estimated up to 96 h in primary microglia. As shown in Fig. 6K, LPS-induced phosphorylation of p38 MAPK was detected transiently only at 0.5 h after the addition of LPS, but not at 24 h. These results exclude the possibility that LPS directly activated p38 MAPK during phagocytosis of axon debris in primary microglia. In a separate series of experiments, the effect of SB203580 on engulfment of degenerating neurites by LPS-stimulated primary microglia was assessed. LPS-stimulated primary microglia engulfed degenerating axons (reduced to 28.0% ± 4.5% of control), which were partially but significantly blocked by SB203580 (reduced to 53.3% ± 8.1% of control) (Fig. 6, L–O). Taken together, these data demonstrated that activation of p38 MAPK was required for engulfment of degenerating axons by primary microglia and MG5 cells.
The Mechanism of Microglial Recognition of Axon Debris Appears to Be Different from That of Apoptotic Cells
Because clearance of the proximal neurites from the transected site was not observed, our results demonstrated that activated primary microglia as well as MG5 cells recognized specifically degenerated debris. Thus, we assumed that the binding of some ligand(s) on the debris to some receptor(s) on the microglia initiated the phagocytic process. We hypothesized that receptors recognizing apoptotic cellular material such as phosphatidylserine (15, 16) might be involved in this process. These receptors include T-cell immunoglobulin-and mucin-domain-containing molecule-4 (Tim-4) and brain-specific angiogenesis inhibitor 1 (BAI1). It has been reported that the expression level of Tim-4 in the brain is very weak compared with that in the spleen, thymus, lymph nodes, and salivary glands (15). In the present study, we obtained results that were consistent with these findings (Fig. 7A, left). Next, we examined the Tim-4 mRNA expression in MG5 cells before and after axotomy. As shown in Fig. 7A, the expression level of Tim-4 mRNA in MG5 cells was very low in the control state and was not changed after transection of the neurites (Fig. 7A, right). The next hypothesis we tested was that the microglial receptor could function as a sensor for phagocytosis by sensing diffusible factors. It has been reported that the microglial metabotropic P2Y6 receptor recognizes the nucleotide UDP released from kainic acid (KA)-treated dying neurons and stimulates microglial phagocytosis (17). We examined whether the microglial P2Y6 receptor contributed to engulfment of degenerating axons. As shown in Fig. 7, B–E, MG5 cells engulfed degenerating axons (reduced to 37.6% ± 4.8% of control) that were not blocked by the P2Y6 receptor antagonist MRS2578 (10 μm) (reduced to 43.8% ± 3.7% of control). However, MG5 cells engulfed staurosporine-induced apoptotic neurons, which were partially blocked by MRS2578 (Fig. 7, F–H and J). These results exclude the possibility that the P2Y6 receptor is necessary for microglial cells to be phagocytic of degenerated axons after transection. We also found that the p38 MAPK inhibitor significantly blocked engulfment of dead neurons by MG5 cells (Fig. 7, I and J). Interestingly, the axons undergoing Wallerian degeneration did not seem to possess detectable activation of the caspase family (8). We also confirmed that KA induced LDH release in apoptotic cells but that degenerating axons did not release LDH (Fig. 7K). These results suggest that there are different mechanisms of microglial phagocytosis between dying neurons and degenerating axons and that Wallerian degeneration and apoptosis may represent two distinct self-destruction programs.
DISCUSSION
In the present study, we established a new assay system to estimate phagocytosis of axon debris by microglia in vitro. Some of the key events during in vivo microglial activation appeared to occur in our system. Microglia efficiently engulfing the axon debris in this system showed high motility and morphological changes similar to the reported observations in vivo (18, 19). Interestingly, clearance of degenerated axons allowed axonal regrowth. This result suggests that degenerated axon debris is a potent inhibitory factor of axon regeneration and that phagocytic removal of axon debris by microglia is important for creating a regenerative environment within the CNS. Why can the axons regenerate from injury site simply by clearance of degenerating debris? Axon debris may express some inhibitory factors for regeneration of the injured axons. Indeed, we have preliminary data to support this hypothesis (data not shown). Another possibility is that degenerating debris become a physical barrier for regeneration of the injured axons.
Our assay enabled us to screen molecules involved in microglial phagocytosis. We found that activation of p38 MAPK is necessary for phagocytosis of degenerating axons. p38 MAPK is activated in spinal microglia after nerve injury and contributes to the development and maintenance of neuropathic pain (14, 20). Phagocytosis of amyloid-β (Aβ) by microglia is dependent on the activation of NF-κB and/or p38 MAPK via the Toll-like receptor (TLR)-4 (21). Recent data have shown that phosphatidylinositol 3-kinase and p38 MAPK are involved in LPS-induced microglial phagocytosis of fluorescent material-conjugated Escherichia coli (E. coli) particles (22). LPS binds to TLR-4, which is a type I transmembrane protein whose cytoplasmic signaling domain is known as Toll-interleukin-1 receptor (TIR) (23) and activates NF-κB as well as p38 MAPK and JNK. In our assay system, p38 MAPK was activated during engulfment of degenerating axons by microglia after transection of the axons of the cortical explants without use of LPS in MG5 cells. p38 MAPK might be activated independent of the LPS-TLR signaling pathway during phagocytosis of axon debris, as the expression of TLR4 mRNA in MG5 cells was not induced after transection of the neurites (data not shown). We assume that microglia recognize some molecules on axon debris and become phagocytic through p38 MAPK activation. The phosphorylation level of p38 MAPK was elevated 24 h after transection of axons in primary microglia, and returned to the control level at 48 and 96 h. Thus, activation of p38 MAPK may be required for microglia to become phagocytic, but not for maintaining phagocytic activity. Interestingly, SB203580 did not completely block engulfment of degenerating neurites by primary microglia as well as MG5 cells, as shown in Fig. 6, F and O, suggesting that other signaling molecule(s) may additively be involved in the process.
Primary microglia showed less phagocytic activity toward axon debris than MG5 cells. However, stimulation of the primary microglia with LPS or IFN-β greatly improved the phagocytic activity. These results demonstrate that primary microglia are in the resting state, and that some cytokines or soluble factors are required for acquisition of phagocytic activity. Consistent with this observation in vitro, systemic injection of LPS accelerates phagocytic activity during Wallerian degeneration in the injured CNS (24). However, it should be noted that these activated microglia still recognized only axon debris but not proximal axons, strongly suggesting that LPS or IFN-β is not sufficient to induce phagocytosis, and that there should be a mechanism of debris recognition. Further, microglia secrete a variety of cytokines and soluble factors, including endotoxins and chemokines, in response to physiological stimuli (19, 7). Previous studies have shown that p38 MAPK activation results in increased expression of secreted inflammatory mediators/growth factors, such as IL-1β, IL-6, TNF-α, or BDNF, through the transcription factor NF-κB or ATF-2 (20). It is well known that glial cells secrete a number of growth factors and cytokines, including BDNF and leukemia inhibitory factor (LIF), following PNS injury (25). Thus, these secreted factors may affect the growth of the severed neurites as well as their own phagocytic activity. If this is the case, phagocytic microglia may provide a favorable environment for restoration of the injured neural network by multiple functions. Consistent with this notion, we observed that axon regeneration was facilitated by activated microglia.
Clearance of apoptotic cells is crucial to avoid the diffusion of damaging degradation products into surrounding tissues (26). Phosphatidylserine on the surface of apoptotic cells is considered to be a ligand expressed on phagocytes. Recently, two groups reported identification of phosphatidylserine receptors, Tim-4 and BAI1 (15, 16). BAI1, which is regulated by p53, recruits a Rac-GEF complex to mediate the uptake of apoptotic cells. However, because MG5 cells used in this study were established from p53(−/−) homozygote mice (9), BAI1-independent phagocytic pathways should have been responsible for engulfment of degenerating axons, at least by MG5 cells. Furthermore, the expression level of Tim-4 remained very low during engulfment of degenerating axons, as shown in Fig. 7A. Thus, Tim-4 that recognizes dying neurons appeared not to be involved in the process of phagocytosis of the axon debris, although we could not exclude the possibility that low level of Tim-4 was sufficient for activating the phagocytic signals. The axons undergo degeneration without the death of the parent neurons in response to local neurotrophin deprivation. In addition, the axons undergoing Wallerian degeneration do not exhibit hallmarks of apoptosis (8). These results suggest that Wallerian degeneration and apoptosis may represent two distinct self-destruction programs. Therefore, we assume that the ligands and receptors for phagocytosis of the dying cells may be different from those for phagocytosis of the axon debris. However, the p38 MAPK inhibitor significantly blocked engulfment of dead neurons by MG5 cells. Thus, there may be a common intracellular pathway leading to engulfment of axon debris and dying neurons. Identification of the molecules that activate the signals for phagocytosis of the axon debris will be the next step.
Myelin in the CNS contains several growth inhibitory molecules such as MAG, Nogo, OMgp, and RGMa, which exhibit inhibitory effects on axonal regrowth (27–30). Thus, rapid removal of myelin-associated inhibitors is essential for establishing an environment beneficial for axonal regeneration after CNS injury. However, degenerating debris of myelin is removed only very slowly in the CNS compared with PNS (4, 5). It should be noted that the assay system we employed in the present study lacks myelin which plays the central role in the generation of a non-permissive environment. Thus, our data suggest that axon debris is another inhibitory factor for axon regeneration because the debris inhibited the growth of the severed neurites in vitro. Therefore, elucidation of the mechanism of phagocytosis of the debris may be useful in developing therapeutic agents against CNS injuries.
In summary, we established an efficient in vitro assay system to estimate microglial phagocytosis and identified p38 MAPK as a requirement for the phagocytic activity. We observed regrowth of the severed neurites after elimination of the axon debris, suggesting that axon debris is another inhibitory factor for axon regeneration. This assay system will be useful in finding the ligands on the debris, receptors on microglia, and the downstream molecular events that involve p38 MAPK.
Supplementary Material
Acknowledgment
We thank Kazutoshi Kiuchi (Gifu University) for the gift of the MG5 microglial cell line.
This work was supported by a research grant from the National Institute of Biomedical Innovation (05-12) and a Grant-in-Aid for Young Scientists (S) from the Japan Society for the Promotion of Science.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Movie S1.
- CNS
- central nervous system
- MAPK
- mitogen-activated protein kinase
- DMEM
- Dulbecco's modified Eagle's medium
- LDH
- lactate dehydrogenase
- IFN-β
- interferon-β.
REFERENCES
- 1.Waller A. (1850) Phil. Trans. R Soc. Lond. 140, 423–429 [Google Scholar]
- 2.Raff M. C., Whitmore A. V., Finn J. T. (2002) Science 296, 868–871 [DOI] [PubMed] [Google Scholar]
- 3.Coleman M. (2005) Nat. Rev. Neurosci. 6, 889–898 [DOI] [PubMed] [Google Scholar]
- 4.George R., Griffin J. W. (1994) Exp. Neurol. 129, 225–236 [DOI] [PubMed] [Google Scholar]
- 5.Stoll G., Jander S. (1999) Prog. Neurobiol. 58, 233–247 [DOI] [PubMed] [Google Scholar]
- 6.Kuan C. Y., Roth K. A., Flavell R. A., Rakic P. (2000) Trends Neurosci. 23, 291–297 [DOI] [PubMed] [Google Scholar]
- 7.Hanisch U. K., Kettenmann H. (2007) Nat. Neurosci. 10, 1387–1394 [DOI] [PubMed] [Google Scholar]
- 8.Finn J. T., Weil M., Archer F., Siman R., Srinivasan A., Raff M. C. (2000) J. Neurosci. 20, 1333–1341 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Ohsawa K., Imai Y., Nakajima K., Kohsaka S. (1997) Glia 21, 285–298 [PubMed] [Google Scholar]
- 10.Yamagishi S., Fujitani M., Hata K., Kitajo K., Mimura F., Abe H., Yamashita T. (2005) J. Biol. Chem. 280, 20384–20388 [DOI] [PubMed] [Google Scholar]
- 11.Chan A., Seguin R., Magnus T., Papadimitriou C., Toyka K. V., Antel J. P., Gold R. (2003) Glia 43, 231–242 [DOI] [PubMed] [Google Scholar]
- 12.Goslin K., Schreyer D. J., Skene J. H., Banker G. (1988) Nature 336, 672–674 [DOI] [PubMed] [Google Scholar]
- 13.Bhat N. R., Zhang P., Lee J. C., Hogan E. L. (1998) J. Neurosci. 18, 1633–1641 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Tsuda M., Mizokoshi A., Shigemoto-Mogami Y., Koizumi S., Inoue K. (2004) Glia 45, 89–95 [DOI] [PubMed] [Google Scholar]
- 15.Miyanishi M., Tada K., Koike M., Uchiyama Y., Kitamura T., Nagata S. (2007) Nature 450, 435–439 [DOI] [PubMed] [Google Scholar]
- 16.Park D., Tosello-Trampont A. C., Elliott M. R., Lu M., Haney L. B., Ma Z., Klibanov A. L., Mandell J. W., Ravichandran K. S. (2007) Nature 450, 430–434 [DOI] [PubMed] [Google Scholar]
- 17.Koizumi S., Shigemoto-Mogami Y., Nasu-Tada K., Shinozaki Y., Ohsawa K., Tsuda M., Joshi B. V., Jacobson K. A., Kohsaka S., Inoue K. (2007) Nature 446, 1091–1095 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Kreutzberg G. W. (1996) Trends Neurosci. 19, 312–318 [DOI] [PubMed] [Google Scholar]
- 19.Garden G. A., Möller T. (2006) J Neuroimmune Pharmacol. 1, 127–137 [DOI] [PubMed] [Google Scholar]
- 20.Ji R. R., Suter M. R. (2007) Mol. Pain 3, 33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Kakimura J., Kitamura Y., Takata K., Umeki M., Suzuki S., Shibagaki K., Taniguchi T., Nomura Y., Gebicke-Haerter P. J., Smith M. A., Perry G., Shimohama S. (2002) FASEB J. 16, 601–603 [DOI] [PubMed] [Google Scholar]
- 22.Sun H. N., Kim S. U., Lee M. S., Kim S. K., Kim J. M., Yim M., Yu D. Y., Lee D. S. (2008) Biol. Pharm. Bull. 31, 1711–1715 [DOI] [PubMed] [Google Scholar]
- 23.O'Neill L. A., Dinarello C. A. (2000) Immunol. Today 21, 206–209 [DOI] [PubMed] [Google Scholar]
- 24.Vallières N., Berard J. L., David S., Lacroix S. (2006) Glia 53, 103–113 [DOI] [PubMed] [Google Scholar]
- 25.Boyd J. G., Gordon T. (2003) Mol. Neurobiol. 27, 277–324 [DOI] [PubMed] [Google Scholar]
- 26.Lauber K., Blumenthal S. G., Waibel M., Wesselborg S. (2004) Mol. Cell 14, 277–287 [DOI] [PubMed] [Google Scholar]
- 27.Mukhopadhyay G., Doherty P., Walsh F. S., Crocker P. R., Filbin M. T. (1994) Neuron 13, 757–767 [DOI] [PubMed] [Google Scholar]
- 28.Chen M. S., Huber A. B., van der Haar M. E., Frank M., Schnell L., Spillmann A. A., Christ F., Schwab M. E. (2000) Nature 403, 434–439 [DOI] [PubMed] [Google Scholar]
- 29.Wang K. C., Koprivica V., Kim J. A., Sivasankaran R., Guo Y., Neve R. L., He Z. (2002) Nature 417, 941–944 [DOI] [PubMed] [Google Scholar]
- 30.Hata K., Fujitani M., Yasuda Y., Doya H., Saito T., Yamagishi S., Mueller B. K., Yamashita T. (2006) J. Cell Biol. 173, 47–58 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.